Respiratory syncytial virus (RSV) is associated with a considerable burden of hospitalizations, intensive care unit (ICU) admissions, and in-hospital deaths among adults.
Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years.